By East Arizona News |
Apr 1, 2024
U.S. Representative David Schweikert recently introduced the Substance Therapy Designation Act, a bill aimed at expediting the development and review of treatments targeting addictive substances such as opioids, cocaine, methamphetamine, and alcohol. The legislation would allow these substances to be eligible for an FDA breakthrough therapy designation, ultimately speeding up the process of bringing effective treatments to those in need.Speaking about the bill, Rep. Schweikert highlighted the urgency of addressing the ongoing crisis of illicit drugs flowing into the...